Ainos (OTCMKTS:AIMD) Shares Down 1.8% – Should You Sell?

Ainos, Inc. (OTCMKTS:AIMD)’s stock price traded down 1.8% on Tuesday . The company traded as low as $0.52 and last traded at $0.54. 87,209 shares were traded during trading, a decline of 85% from the average session volume of 567,033 shares. The stock had previously closed at $0.55.

Ainos Trading Down 1.8%

The business has a 50-day moving average price of $0.53 and a two-hundred day moving average price of $0.54. The stock has a market capitalization of $8.33 million, a P/E ratio of -0.62 and a beta of 2.14. The company has a current ratio of 1.92, a quick ratio of 1.45 and a debt-to-equity ratio of 0.08.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.